Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | lanosterol synthase | 0.0474 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0367 | 0.3313 | 0.5 |
Giardia lamblia | Macrophage migration inhibitory factor | 0.0367 | 0.3313 | 0.5 |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.0367 | 0.3313 | 0.5 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.0367 | 0.3313 | 0.5 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.0367 | 0.3313 | 0.5 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.0367 | 0.3313 | 0.5 |
Mycobacterium tuberculosis | Halimadienyl diphosphate synthase | 0.0315 | 0 | 0.5 |
Brugia malayi | Bm-MIF-1, identical | 0.0367 | 0.3313 | 0.5 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0474 | 1 | 0.5 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.0367 | 0.3313 | 0.5 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.0367 | 0.3313 | 0.5 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0474 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Log IC50 (binding) | = 6.3 | Inhibition of oxidosqualene cyclase | ChEMBL. | 17760433 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.